Skip to main content
Back to feed
HealthSingle-sourceLow
2.1

NHS England approves Fampridine for multiple sclerosis patients

NHS England has authorized the use of Fampridine to improve walking ability in patients with multiple sclerosis. Approximately 5,000 patients are estimated to be eligible for the treatment, which functions by enhancing nerve signal conduction.

BBC Newsabout 12 hours agoGBCredibility 31%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

#health#pharmaceuticals#nhs#multiple sclerosis

Locations

England

Entities

country
Source

Related signals

8 found